Rhinospray plus Uses, Dosage, Side Effects and more
Rhinospray plus is under investigation in clinical trial NCT01601509 (Nasal Rhinospray plus and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Rhinospray plus and).
| Trade Name | Rhinospray plus |
| Generic | Tramazoline |
| Tramazoline Other Names | Tramazolina, Tramazoline |
| Type | |
| Formula | C13H17N3 |
| Weight | Average: 215.3 Monoisotopic: 215.142247559 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Austria, Germany |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Rhinospray plus is a sympathomimetic indicated for nasal decongestion.
Rhinospray plus is also used to associated treatment for these conditions: Nasal Congestion
